Cargando…
Understanding the Association between Red Blood Cell Transfusion Utilization and Humanistic and Economic Burden in Patients with β-Thalassemia from the Patients’ Perspective
We assessed the humanistic and economic burden of chronic red blood cell (RBC) transfusions on patients with β-thalassemia. This cross-sectional, US-based study included adults (≥18 years) who self-reported a β-thalassemia physician diagnosis and had received ≥1 RBC transfusion in the past 6 months....
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861260/ https://www.ncbi.nlm.nih.gov/pubmed/36675342 http://dx.doi.org/10.3390/jcm12020414 |
_version_ | 1784874796958351360 |
---|---|
author | Knoth, Russell L. Gupta, Shaloo Perkowski, Kacper Costantino, Halley Inyart, Brian Ashka, Lauren Clapp, Kelly |
author_facet | Knoth, Russell L. Gupta, Shaloo Perkowski, Kacper Costantino, Halley Inyart, Brian Ashka, Lauren Clapp, Kelly |
author_sort | Knoth, Russell L. |
collection | PubMed |
description | We assessed the humanistic and economic burden of chronic red blood cell (RBC) transfusions on patients with β-thalassemia. This cross-sectional, US-based study included adults (≥18 years) who self-reported a β-thalassemia physician diagnosis and had received ≥1 RBC transfusion in the past 6 months. The outcomes included the Functional Assessment of Cancer Therapy-Anemia (FACT-An), Patient Health Questionnaire-9, Generalized Anxiety Disorder-7, and ad hoc questions about treatment experience, side effects, direct/indirect costs, and psychological burden. Overall, 100 patients completed the survey, of whom 70% experienced “moderate” to “extremely high” burden due to RBC transfusions, 81% reported iron overload, 42% reported compromised social lives. The mean FACT-An score was 132 (higher score indicates better outcomes; 0–188). Mean scores were 33/52 for fatigue and 20/28 for anemia symptoms in the previous 7 days. Health-related quality of life (HRQoL) temporarily improved after RBC transfusion, although patients continued to experience mild-to-severe depression and anxiety, substantial direct costs, compromised employment, and suboptimal quality of life. Over 6 months, patients dedicated a mean of 173 h to transfusion requirements and incurred out-of-pocket costs of USD 2239 for transfusions and USD 896 for additional care costs. These findings highlight the need for new treatment options to improve patient HRQoL and economic outcomes. |
format | Online Article Text |
id | pubmed-9861260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98612602023-01-22 Understanding the Association between Red Blood Cell Transfusion Utilization and Humanistic and Economic Burden in Patients with β-Thalassemia from the Patients’ Perspective Knoth, Russell L. Gupta, Shaloo Perkowski, Kacper Costantino, Halley Inyart, Brian Ashka, Lauren Clapp, Kelly J Clin Med Article We assessed the humanistic and economic burden of chronic red blood cell (RBC) transfusions on patients with β-thalassemia. This cross-sectional, US-based study included adults (≥18 years) who self-reported a β-thalassemia physician diagnosis and had received ≥1 RBC transfusion in the past 6 months. The outcomes included the Functional Assessment of Cancer Therapy-Anemia (FACT-An), Patient Health Questionnaire-9, Generalized Anxiety Disorder-7, and ad hoc questions about treatment experience, side effects, direct/indirect costs, and psychological burden. Overall, 100 patients completed the survey, of whom 70% experienced “moderate” to “extremely high” burden due to RBC transfusions, 81% reported iron overload, 42% reported compromised social lives. The mean FACT-An score was 132 (higher score indicates better outcomes; 0–188). Mean scores were 33/52 for fatigue and 20/28 for anemia symptoms in the previous 7 days. Health-related quality of life (HRQoL) temporarily improved after RBC transfusion, although patients continued to experience mild-to-severe depression and anxiety, substantial direct costs, compromised employment, and suboptimal quality of life. Over 6 months, patients dedicated a mean of 173 h to transfusion requirements and incurred out-of-pocket costs of USD 2239 for transfusions and USD 896 for additional care costs. These findings highlight the need for new treatment options to improve patient HRQoL and economic outcomes. MDPI 2023-01-04 /pmc/articles/PMC9861260/ /pubmed/36675342 http://dx.doi.org/10.3390/jcm12020414 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Knoth, Russell L. Gupta, Shaloo Perkowski, Kacper Costantino, Halley Inyart, Brian Ashka, Lauren Clapp, Kelly Understanding the Association between Red Blood Cell Transfusion Utilization and Humanistic and Economic Burden in Patients with β-Thalassemia from the Patients’ Perspective |
title | Understanding the Association between Red Blood Cell Transfusion Utilization and Humanistic and Economic Burden in Patients with β-Thalassemia from the Patients’ Perspective |
title_full | Understanding the Association between Red Blood Cell Transfusion Utilization and Humanistic and Economic Burden in Patients with β-Thalassemia from the Patients’ Perspective |
title_fullStr | Understanding the Association between Red Blood Cell Transfusion Utilization and Humanistic and Economic Burden in Patients with β-Thalassemia from the Patients’ Perspective |
title_full_unstemmed | Understanding the Association between Red Blood Cell Transfusion Utilization and Humanistic and Economic Burden in Patients with β-Thalassemia from the Patients’ Perspective |
title_short | Understanding the Association between Red Blood Cell Transfusion Utilization and Humanistic and Economic Burden in Patients with β-Thalassemia from the Patients’ Perspective |
title_sort | understanding the association between red blood cell transfusion utilization and humanistic and economic burden in patients with β-thalassemia from the patients’ perspective |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861260/ https://www.ncbi.nlm.nih.gov/pubmed/36675342 http://dx.doi.org/10.3390/jcm12020414 |
work_keys_str_mv | AT knothrusselll understandingtheassociationbetweenredbloodcelltransfusionutilizationandhumanisticandeconomicburdeninpatientswithbthalassemiafromthepatientsperspective AT guptashaloo understandingtheassociationbetweenredbloodcelltransfusionutilizationandhumanisticandeconomicburdeninpatientswithbthalassemiafromthepatientsperspective AT perkowskikacper understandingtheassociationbetweenredbloodcelltransfusionutilizationandhumanisticandeconomicburdeninpatientswithbthalassemiafromthepatientsperspective AT costantinohalley understandingtheassociationbetweenredbloodcelltransfusionutilizationandhumanisticandeconomicburdeninpatientswithbthalassemiafromthepatientsperspective AT inyartbrian understandingtheassociationbetweenredbloodcelltransfusionutilizationandhumanisticandeconomicburdeninpatientswithbthalassemiafromthepatientsperspective AT ashkalauren understandingtheassociationbetweenredbloodcelltransfusionutilizationandhumanisticandeconomicburdeninpatientswithbthalassemiafromthepatientsperspective AT clappkelly understandingtheassociationbetweenredbloodcelltransfusionutilizationandhumanisticandeconomicburdeninpatientswithbthalassemiafromthepatientsperspective |